ATYR FY 2019 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$422,000

Gross Profit

-$14M-3228.9% margin

Operating Income

-$23M-5445.0% margin

Net Income

-$24M-5593.1% margin

EPS (Diluted)

$-7.03

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$36M

Total Liabilities

$15M

Stockholders' Equity

$21M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$422,000	$0	—
Gross Profit	-$14M	-$746,000	-1726.5%
Operating Income	-$23M	-$33M	+30.0%
Net Income	-$24M	-$35M	+31.6%